Human medicines European public assessment report (EPAR): Puregon, follitropin beta, Date of authorisation: 02/05/1996, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Fetcroja, cefiderocol, Date of authorisation: 23/04/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): RotaTeq, rotavirus vaccine, live, Date of authorisation: 26/06/2006, Revision: 39, Status: Authorised

Human medicines European public assessment report (EPAR): Orgalutran, ganirelix, Date of authorisation: 16/05/2000, Revision: 26, Status: Authorised

EMA - European Consumer Organisation (BEUC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 10 November 2025

List of medicines currently in PRIME scheme

Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 4, Status: Withdrawn

Human medicines European public assessment report (EPAR): Blarcamesine Anavex, blarcamesine, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence, Date of authorisation: 26/05/2016, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 14, Status: Authorised